Hot Deals:
a v thomas 11,770.00 (-0.25 %) adtech 29.00 (-3.33 %) amol minechem 620.00 (1.64 %) anand i-power 20.00 anglo french 370.00 (-2.37 %) aricent 575.00 (0.88 %) arkfin investments 50.00 arohan 181.00 (0.56 %) assam carbon 227.00 (-1.30 %) associated pigments 42.00 (-4.55 %) atlas copco 9,100.00 (1.11 %) auckland international 130.00 (-3.70 %) axles 162.00 (1.25 %) balmer lawrie 300.00 bharat hotels 162.00 (1.25 %) bima mandi 700.00 bira 91 750.00 (-2.85 %) boat 829.00 (-0.12 %) c & s electric 470.00 (-4.08 %) capgemini 12,100.00 (1.68 %) care health 135.00 (3.85 %) carrier aircon 260.00 (1.96 %) cial 180.00 (-1.64 %) csfbl 265.00 (-3.64 %) csk 170.00 (6.25 %) dalmia refract 81.00 (-4.71 %) dsp merrill lynch 1,000.00 east india pharma 44.00 (2.33 %) eaton fluid 380.00 (1.33 %) electronica plastic 4,100.00 (-4.65 %) elgi ultra 400.00 elofic 1,909.00 (0.47 %) esl steel 39.00 (11.43 %) fincare business 43.00 fincare sfbl 74.00 (1.37 %) fino paytech 160.00 (14.29 %) frick india 3,806.00 (0.16 %) gkn drive 1,240.00 (-0.80 %) go digit gil 354.00 (1.14 %) godavari bio 71.00 (1.43 %) hdbfsl 590.00 (-1.67 %) hdfc ergo 370.00 (1.70 %) hdfc securities 11,200.00 (-2.61 %) hella india 350.00 (6.06 %) hero fincorp 690.00 (-3.36 %) hicks 2,100.00 (-2.55 %) hira ferro 120.00 (-0.83 %) honeywell electrical 3,555.00 (-1.25 %) icex 5.00 (-0.20 %) incred financial 100.00 india carbon 1,010.00 (1.00 %) india exposition 146.00 (0.69 %) indian potash 1,405.00 (0.36 %) indofil 690.00 (-2.82 %) infinite computer 700.00 inkel 12.95 (-0.38 %) ixigo 97.00 (-2.02 %) jana sfbl 75.00 kel 630.00 (-1.56 %) kial 107.00 (-2.73 %) kurlon limited 426.00 (-3.18 %) lava 127.00 (0.79 %) manipal hfsl 72.50 (0.69 %) manjushree tech 970.00 (-3.10 %) martin & harris 1,500.00 (0.33 %) merino 2,770.00 (0.73 %) minosha 280.00 (-3.45 %) mitsubishi heavy 355.00 (1.43 %) mkcl 415.00 (1.22 %) mobikwik 425.00 (-5.56 %) mohan meakin 1,180.00 (-2.64 %) mohfl 10.75 (-9.66 %) msei 0.98 (-2.00 %) msil 56.00 (3.70 %) nayara energy 152.00 (0.66 %) nayara energy ncd 250.00 ncdex 275.00 ncl buildtek 190.00 (-5.00 %) ncl holdings 50.00 (5.26 %) nse 3,100.00 (1.64 %) orbis financial 86.00 (1.18 %) oswal minerals 65.00 (1.56 %) otis 3,700.00 (-2.63 %) oyo rooms 69.00 (-2.82 %) panasonic appliances 293.00 (-4.25 %) panasonic avc 29.10 (0.34 %) paymate india 600.00 (-3.38 %) pharma easy 32.00 (-8.57 %) philips domestic 605.00 (0.83 %) philips india 1,100.00 (1.85 %) pnb metlife 70.00 proyuga adtech 25.00 purity flexpack 20.00 ramaraju surgical 490.00 (-2.00 %) rasoi 32,000.00 (3.23 %) reliance gic 340.00 resins plastics 414.00 (1.97 %) ring plus 370.00 (1.37 %) rrl 2,800.00 (-1.75 %) sab miller 303.00 (1.00 %) satya micro 201.00 (0.50 %) scottish assam 500.00 (-3.85 %) shriram life 251.00 (0.40 %) sigachi lab 40.10 (0.25 %) signify 1,100.00 (4.46 %) simpson & company 3,500,000.00 smile micro 52.00 (-1.89 %) sportskeeda 3,303.00 sterlite power 524.00 (0.19 %) studds 950.00 (-0.52 %) svsml 510.00 (-2.30 %) t stanes 675.00 tata capital 56.00 (1.82 %) tata tech 5,400.00 (4.85 %) teesta agro 67.00 (-4.29 %) trl krosaki 1,224.00 (-2.16 %) utkarsh coreinvest 127.00 (-2.31 %) vikram solar 55.50 (-0.89 %) xerox 243.00 (1.25 %)
×

east india pharmaceutical works Limited

44.00
+ 2.33 %
Scrip Name
East India Pharma
ISIN No.
INE254X01017
PAN No.
AAACE5779P
Face Value
10
No. of Outstanding Shares
6,674,858
Market Capitalization
29.37 Crore

About EAST INDIA PHARMACEUTICAL WORKS LIMITED Unlisted Shares 

East India Pharmaceutical Works Limited (EIPW) is one of the oldest pharmaceutical companies in India, Founded on 27 April 1936, it is involved in the Manufacturing of Healthcare Products. It is registered at the registrar of companies in Kolkata. The authorized equity share capital of the company is Rs. 10,00,00,000 and the paid-up capital is Rs. 6,67,45,180.

The Company has over 87 years of experience and has a focused “people-centric approach” which enabled it to evolve with ever-changing healthcare needs and it offers high-quality advanced medicines for modern-day health complexities.

Along with its high-quality products and experienced medical and research team, backed by the most advanced and precise equipment and infrastructure, the company ensures international quality standards at every stage of production. East India Pharmaceutical is focused to use cost-effective processes to produce high-volume formulations. The company has achieved GMP, WHO-GMP, and GLP certifications.

INCORPORATION DETAILS

CIN

U24231WB1936PLC008598

Registration Date

27 April 1936

Company Name

EAST INDIA PHARMACEUTICAL WORKS LIMITED

Email Address

[email protected]

Category/Sub-category of the Company

Company Limited by Shares/Non-Government Company

Class of Company

Public

Registration Number

8598

Banker

Punjab National Bank

Address of the Registered office & contact details

6, Nandalal Bose Sarani, Kolkata 700 071

Statutory Auditors

M/s APS Associates Chartered Accountants

Cost Auditors

M/s DGM & Associates Cost Accountants

Company Secretary

Ms. Jayeeta Sarkar

Registrar and Share Transfer Agent

C B Management Services (P) Ltd. P-22, Bondel Road, Kolkata - 700 019

Listing Status

Unlisted

PARTICULAR OF SUBSIDIARY COMPANIES

Name of the Company

Subsidiary

% of shares held

Qasar Healthcare Private Limited

Subsidiary

99.5%

BOARD OF DIRECTORS

Mr. Debarshi Duttagupta (Managing Director)

Mrs. Satarupa Mukherjee (Executive Director)

Prof. (Dr.) Ranabir Mukherjee

Mr. Probir Roy (Chairman)

Mr. Dilip Samadar (Member)

Prof. (Dr.) Suman Kumar Mukerjee

Mr. Sukamal Chandra Basu (Member)

Mr. Chiraranjan Addy

Prof. (Dr.) Himadri Sengupta

Dr. Abhijit Banerjee

Dr.Tapas Raychaudhury

Mrs. Indrani Sen

Mrs. Sanghamitra Duttagupta

Mrs. Trishna Guha

 Principal Business Activities of the Company

Name & Description of main products/services

NIC Code of the Product /service

% to total turnover of the company

Manufacture of bulk drugs, Manufacture & sale of formulations & Trading Activities

210

100%

 

SHAREHOLDING PATTERN (As of 31-03-2021)

S. No.

Shareholder’s Category

No. of Shares

% of total Shares of the company

1

PROMOTERS

20,09,361

30.11%

2

PUBLIC

46,65,497

69.89%

 

Total

66,74,858

100%

Industry Outlook

The company is one of the oldest pharmaceutical companies in India that develops, manufactures, and markets high-quality medicines. The company has two manufacturing plants, one in Durgapur and one in Kolkata, with cutting-edge production facilities. The rapid spread of the COVID-19 pandemic had a significant impact on global economic activity. In India, like other countries around the world, has been severely impacted. IMF forecasts a 4.5 percent contraction in India for 2021. Finance Minister announced an additional outlay of Rs. 1,97,000 crore (USD 26,578.3 million) for the pharmaceutical Production Linked Incentive (PLI) scheme.

FY 2020-2021 Highlights of Company

  • Turnover at Rs. 1,72,69,64,586
  • Profit before Tax at Rs. 5,50,87,817

 

PROFIT & LOSS STATEMENT OF EAST INDIA PHARMACEUTICAL WORKS LIMITED (In Rs.)

(As of 31-03-2019 to 31-03-2021)

Particular

2021

2020

2019

Revenue

     

Revenue from Operations

1,72,67,84,326

1,58,39,11,504

1,61,28,72,834

Other Income

1,80,260

15,71,901

12,35,696

Total Revenue

1,72,69,64,586

1,58,54,83,405

1,61,41,08,530

Expenses

     

Cost of materials consumed

49,96,34,132

46,57,72,212

45,62,48,199

Purchases of Traded Goods

1,71,87,443

1,77,56,384

1,26,64,335

Finished goods, Work-in-Progress, and Traded Goods

2,83,85,036

(4,58,18,931)

(1,19,97,983

Employee Benefits Expenses

63,98,08,743

59,20,38,256

54,00,90,712

Finance Costs

5,05,30,470

5,55,92,371

5,69,63,781

Depreciation and Amortisation Expenses

2,60,54,248

3,03,52,719

1,63,96,508

Research and Development Expenses

1,35,43,417

1,36,07,606

1,18,54,490

Other Expenses

39,67,63,227

42,54,57,542

51,58,75,286

Total Expenses

1,67,19,06,716

1,55,47,58,159

1,59,80,95,328

Profit / (Loss) Before Tax

5,50,57,870

3,07,25,246

1,60,13,202

Tax Expenses

     

         Current tax

2,50,00,000

1,00,00,000

45,00,000

         Deferred tax

(65,97,317)

(45,64,268)

(26,25,388)

         Tax Adj. of earlier Years

51,99,659

52,41,291

14,72,927

Total

2,36,02,342

1,06,77,023

33,47,539

Profit / (Loss) For the Year 

3,14,55,528

2,00,48,223

1,26,65,663

Earnings Per Equity Shares

     

    Earnings Per Equity Shares (Basic)

4.71

3.00

1.90

    Earnings Per Equity Shares (Diluted)

4.71

3.00

1.90

 

BALANCE SHEET OF EAST INDIA PHARMACEUTICAL WORKS LIMITED (In Rs.) (As of 31-03-2019 to 31-03-2021)

PARTICULARS

2021

2020

2019

EQUITY AND LIABILITIES:

     

Share Capital

6,67,45,179

6,67,45,179

6,67,45,179

Reserves and Surplus

40,56,16,066

38,08,35,247

36,48,10,162

Minority Interest

(45,888)

(45,738)

(45,635)

Non-Current Liabilities:

     

Long-Term Borrowings

4,23,36,281

32,67,440

12,40,426

Long-Term Provisions

8,14,91,000

6,43,20,000

5,51,46,000

Current Liabilities:

     

Short-Term Borrowings

32,19,00,853

35,31,62,674

31,40,23,439

Trade Payables

34,39,64,616

34,94,48,075

30,64,48,374

Other Current Liabilities

19,62,03,669

17,44,73,972

17,31,13,522

Short-Term Provisions

3,35,77,000

1,65,09,000

90,90,000

TOTAL LIABILITIES

1,49,17,88,776

1,40,87,15,849

1,29,05,71,467

ASSETS

     

Non-Current Assets

     

Fixed Assets

     

      Tangible Assets

15,41,09,850

17,06,81,797

9,63,38,731

      Intangible Assets

7,82,364

8,26,060

9,34,088

      Capital work-in-progress

37,32,327

66,27,594

9,78,80,503

Deferred Tax Assets (Net)

4,89,77,722

4,23,80,405

3,78,16,137

Long-Term Loans and Advances

71,16,873

1,00,86,375

90,98,712

Current Assets

     

Inventories

34,94,30,415

37,83,84,071

26,87,61,911

Trade Receivables

70,98,01,337

57,00,98,674

53,42,38,157

Cash and Cash Equivalents

15,67,73,363

12,68,82,571

16,89,35,815

Short-Term Loans and Advances

6,10,64,525

10,07,48,302

7,45,67,413

Other Current Assets

NIL

20,00,000

20,00,000

TOTAL ASSETS

149,17,88,776

140,87,15,849

129,05,71,467

 

DIVIDEND AND RETAINED EARNINGS (As of 31-03-2019 to 31-03-2021)

Particulars

2021

2020

2019

Dividend (in Rs.)

1.25

1.00

0.50

Retained Earnings

248.11

160.46

126.77

PERFORMANCE OF THE COMPANY

Revenue from operation increased from Rs. 1,58,39,11,504 in FY 2020 to Rs. 1,72,67,84,326 in FY 2021, showing a growth of 9.03% as compared to the previous financial year.

Finance Cost has decreased from Rs. 5,55,92,371 in FY 2020 to Rs.  5,05,30,470 in FY 2021, showing a decline of 9.11% as compared to the previous financial year.

In FY 2021, Company’s Net profit stood at Rs. 3,14,55,528 as against to net profit of Rs. 2,00,48,223 in FY 2020 showing a growth of 56.9% as compared to the previous financial year. 

The Current Ratio of the company as of 31st March 2021 was 1.43.

 The debt-to-equity ratio of the company as of 31st March 2021 was 3.16.

The Company paid a dividend of Rs. 1.25 in the financial year 2020-2021

Annual Reports

2021-22

Download

2020-21

Download

2019-20

Download
Wealth Wisdom - WWIPL
Support Megha Support Neha Support Pallavi